Stephen R Ash Selected Research

Renin

8/2015

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen R Ash Research Topics

Disease

4	Chronic Renal Insufficiency 04/2024 - 08/2015
4	Chronic Kidney Failure (Chronic Renal Failure) 04/2023 - 04/2011
4	Liver Failure 11/2007 - 01/2002
3	Hyperkalemia 04/2024 - 08/2015
3	Sepsis (Septicemia) 09/2022 - 01/2002
3	Drug Overdose 04/2022 - 01/2002
3	Infections 06/2009 - 03/2006
2	Acidosis 04/2024 - 01/2022
2	Hernia (Hernias) 01/2013 - 04/2002
2	Pathologic Constriction (Stenosis) 01/2013 - 11/2008
2	Hemorrhage 04/2011 - 05/2009
2	Thrombosis (Thrombus) 04/2011 - 09/2008
2	Catheter-Related Infections 11/2008 - 01/2000
2	Bacteremia 03/2006 - 01/2000
2	Brain Diseases (Brain Disorder) 01/2002 - 01/2002
1	Hepatic Encephalopathy 04/2022
1	Constipation 08/2015
1	Shock 01/2013
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 01/2013
1	Thrombocytopenia (Thrombopenia) 04/2011
1	Renal Insufficiency (Renal Failure) 11/2009
1	Wounds and Injuries (Trauma) 11/2008
1	Acute-On-Chronic Liver Failure 04/2006
1	Acute Kidney Injury (Acute Renal Failure) 03/2005
1	Peritonitis 04/2002
1	Pneumonia (Pneumonitis) 01/2002
1	Cardiotoxicity 01/2002
1	Hypotension (Low Blood Pressure) 01/2002
1	Hepatitis 01/2002
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2002
1	Disease Progression 01/2002
1	Coma (Comas) 01/2002

Drug/Important Bio-Agent (IBA)

5	Bicarbonates (Hydrogen Carbonate)IBA 04/2024 - 01/2002
4	Heparin (Liquaemin)FDA LinkGeneric 04/2011 - 01/2000
3	PotassiumIBA 04/2024 - 08/2015
3	CationsIBA 01/2023 - 01/2002
3	Dialysis SolutionsIBA 04/2022 - 04/2006
3	SolutionsIBA 04/2011 - 01/2000
2	sodium zirconium cyclosilicateIBA 04/2024 - 01/2022
2	Urea (Carbamide)FDA LinkGeneric 01/2023 - 01/2022
2	Methylene Blue (Methylthioninium Chloride)FDA Link 04/2011 - 03/2006
2	SuspensionsIBA 04/2006 - 11/2004
1	FluorocarbonsIBA 01/2023
1	Ammonium CompoundsIBA 01/2023
1	CarbonIBA 04/2022
1	AlbuminsIBA 04/2022
1	AngiotensinsIBA 08/2015
1	AldosteroneIBA 08/2015
1	ReninIBA 08/2015
1	Phenobarbital (Luminal)FDA Link 04/2011
1	Sodium Citrate FDA LinkGeneric 04/2011
1	methylparaben FDA LinkGeneric 04/2011
1	propylparaben FDA LinkGeneric 04/2011
1	Uremic ToxinsIBA 11/2009
1	ElectrolytesIBA 11/2009
1	AnticoagulantsIBA 05/2009
1	Local Anti-Infective Agents (Antiseptics)IBA 11/2008
1	Proteins (Proteins, Gene)FDA Link 01/2002
1	Charcoal (Charbon)IBA 01/2002
1	Bile Acids and Salts (Bile Acids)IBA 01/2002
1	BilirubinIBA 01/2002
1	Alanine Transaminase (SGPT)IBA 01/2002
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2002
1	Citric Acid (Citrate)FDA LinkGeneric 01/2000
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2000

Therapy/Procedure

9	Catheters 09/2022 - 01/2000
5	Therapeutics 01/2022 - 01/2002
5	Renal Dialysis (Hemodialysis) 01/2013 - 04/2006
3	Central Venous Catheters 01/2013 - 01/2000
2	Peritoneal Dialysis 01/2013 - 03/2005
1	Artificial Kidneys 04/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2023
1	Artificial Liver (Bioartificial Liver) 11/2007
1	Mechanical Ventilators (Ventilator) 01/2002
1	Hemoperfusion 01/2002